Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

House committee withdraws James Comey subpoena for Jeffrey Epstein testimony

by admin October 8, 2025
October 8, 2025
House committee withdraws James Comey subpoena for Jeffrey Epstein testimony

The House Oversight Committee has dropped its subpoena for former FBI Director James Comey, after he said he had no knowledge relevant to the panel’s investigation into Jeffrey Epstein, The Hill reported, citing a letter Comey sent to the committee.

In the Oct. 1 letter sent to Committee Chair James Comer, R-Ky, Comey said he had no ‘knowledge’ or ‘information relevant to the Committee’s investigation’ into the late pedophile.

Comey was slated to sit for a deposition on Tuesday before the committee that is examining Epstein’s contacts and potential government ties dating back to the 1990s. 

‘I offer this letter in lieu of a deposition that would unproductively consume the Committee’s scarce time and resources,’ Comey wrote.

Comey served as deputy attorney general from 2003 to 2005 and later as FBI director from 2013 to 2017 — two periods now under scrutiny by House Republicans seeking answers about Epstein’s federal connections.

‘At no time during my service at the Department of Justice or the FBI do I recall any information or conversations that related to Jeffrey Epstein or Ghislaine Maxwell,’ Comey wrote.

Because the letter was submitted under penalty of law — making any false statements a potential federal crime — Comer accepted Comey’s response and withdrew the subpoena.

Fox News Digital has reached out to the Oversight Committee for a copy of Comey’s letter and confirmation of the subpoena’s withdrawal.

The late pedophile Epstein committed suicide in 2019 while awaiting prosecution on federal sex trafficking charges, though questions continue to swirl about the circumstances surrounding his death.

Comer issued a wave of subpoenas in August tied to the Jeffrey Epstein investigation — including to Comey and former President Bill Clinton and former Secretary of State Hillary Clinton.

Comer also subpoenaed the Justice Department for records related to Epstein’s case.

Others ordered to appear include former FBI Director Robert Mueller and former Attorneys General Loretta Lynch, Eric Holder, William Barr, Jeff Sessions and Alberto Gonzales.

Holder and Attorney General Merrick Garland sent letters similar to Comey’s, denying any knowledge of Epstein and prompting Comer to withdraw those subpoenas as well, per The Hill.

It’s unclear if sessions for the Clintons will proceed.

The committee’s work comes amid growing partisan tension over how to handle the Epstein investigation, and the GOP base has fractured over the current administration’s handling of the case.

Top Republicans, including President Donald Trump and Speaker Mike Johnson, R-La., support continuing the Oversight inquiry as the fastest route to uncover new information. Comer has already released thousands of pages of subpoenaed documents from the Justice Department and Epstein’s estate.

Critics, however, accuse the GOP of shielding certain figures by selectively releasing records. Several lawmakers are instead pushing legislation to declassify all government files related to Epstein and Maxwell — a move endorsed by multiple Epstein victims.

Fox News’ Elizabeth Elkind contributed to this report.  

This post appeared first on FOX NEWS

previous post
Government limps deeper into shutdown crisis with no deal in sight
next post
Cruz clashes with Nigeria over his claims 50,000 Christians killed since 2009 in religious violence

Related Posts

Elon Musk’s budget-slashing hits political reality of suffering...

February 19, 2025

Europe steps up to fund its own defense,...

March 12, 2025

Trump issues ‘last warning’ to Hamas terrorists, demands...

March 6, 2025

President Trump to honor Iran strike flight team...

July 5, 2025

House GOP subpoenas Biden aide to testify about...

July 16, 2025

Judicial pushback against Trump’s agenda will likely lead...

February 13, 2025

GOP senator says Dr Oz ignored his questions...

March 26, 2025

Democratic lawmaker ‘no longer on speaking terms’ with...

July 31, 2025

Iran’s Africa activities pose ‘significant threats to US...

July 28, 2025

White House orders Hegseth to stop polygraphs on...

July 28, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved